Alveolar osteitis, commonly referred to as dry socket, is one of the most frequently encountered postoperative complications following tooth extraction. Despite advances in surgical techniques and postoperative care, it remains a persistent clinical challenge in oral and maxillofacial surgery. Dry socket is characterized by severe postoperative pain, partial or complete disintegration of the blood clot within the extraction socket, exposed alveolar bone, and delayed wound healing. The condition typically presents between the second and fourth day after extraction and is often associated with foul odor and halitosis. Although not life-threatening, it significantly impacts patient quality of life, increases the need for emergency visits, and places an additional burden on dental healthcare services.

The reported incidence of alveolar osteitis varies widely in the literature, ranging from approximately 1% to 5% following routine extractions, and up to 20–30% in mandibular third molar surgeries. This variation is influenced by multiple factors including surgical difficulty, operator experience, patient-related risk factors, and local anatomical conditions. The mandible, particularly the posterior region, is more commonly affected due to its relatively poor vascular supply and higher bone density, which can contribute to impaired clot stability and delayed healing.

The etiology of dry socket is multifactorial, although the most widely accepted pathophysiological mechanism involves premature fibrinolysis of the blood clot. Following tooth extraction, a stable blood clot is essential for initiating the wound healing cascade. This clot acts as a biological scaffold that supports cellular migration, angiogenesis, and tissue regeneration. However, in alveolar osteitis, increased plasminogen activator activity leads to excessive fibrinolysis, resulting in breakdown of the fibrin matrix and dislodgement or dissolution of the clot. This exposes the underlying bone and nerve endings, resulting in intense localized pain.

Several contributing risk factors have been identified in the development of dry socket. These include smoking, oral contraceptive use, traumatic tooth extraction, poor oral hygiene, pre-existing infection, and systemic conditions that impair healing. Smoking, in particular, has been strongly associated with increased risk due to its vasoconstrictive effects and interference with normal blood clot formation. Similarly, hormonal influences from estrogen-containing oral contraceptives have been shown to enhance fibrinolytic activity, further predisposing patients to clot breakdown. Surgical trauma, especially during impacted third molar removal, also increases the likelihood of socket disturbance and subsequent alveolar osteitis.

Over the years, numerous preventive strategies have been proposed to reduce the incidence of dry socket. These include the use of antiseptic mouth rinses such as chlorhexidine, systemic or local antibiotics, atraumatic surgical techniques, irrigation of the extraction socket, and placement of medicated dressings. While some of these approaches have demonstrated partial effectiveness, none have consistently eliminated the risk of alveolar osteitis. For example, chlorhexidine mouthwash has been shown in some studies to reduce bacterial load and slightly lower the incidence of dry socket, but its effect is limited and dependent on patient compliance. The use of antibiotics remains controversial due to concerns about antimicrobial resistance and inconsistent evidence of benefit in preventing alveolar osteitis.

Given the limitations of conventional preventive measures, attention has increasingly turned toward biologically based regenerative approaches that actively enhance wound healing rather than merely controlling risk factors. Among these, autologous platelet concentrates, including platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), have gained significant interest in the field of oral and maxillofacial surgery. These biomaterials are derived from the patient’s own blood and are enriched with platelets, growth factors, and cytokines that play a central role in tissue repair and regeneration.

Platelet-rich plasma was one of the earliest platelet concentrates introduced into clinical practice. It is obtained by centrifugation of whole blood to separate plasma with a high concentration of platelets. PRP contains several biologically active molecules, including platelet-derived growth factor (PDGF), transforming growth factor-beta (TGF-β), insulin-like growth factor (IGF), and vascular endothelial growth factor (VEGF). These growth factors contribute to cell proliferation, collagen synthesis, angiogenesis, and overall tissue regeneration. However, PRP requires chemical or exogenous activation to form a gel and has a relatively rapid release of growth factors, which may limit its sustained biological activity.

Platelet-rich fibrin represents a second-generation platelet concentrate that overcomes several limitations associated with PRP. PRF is prepared through a simplified centrifugation process without the addition of anticoagulants or activators. The result is a fibrin matrix that entraps platelets and leukocytes, allowing for a slow and sustained release of growth factors over time. This fibrin scaffold not only enhances biological activity but also provides structural support to the healing socket, promoting stability of the blood clot and protection of the underlying bone. Because of its ease of preparation, biocompatibility, and prolonged release of bioactive molecules, PRF has gained increasing popularity in clinical dental practice.

The biological rationale for the use of platelet concentrates in preventing dry socket is based on their ability to enhance early wound healing and stabilize the post-extraction clot. In normal healing, the blood clot serves as the initial framework for granulation tissue formation. Platelet concentrates reinforce this natural process by increasing clot stability, promoting angiogenesis, and accelerating epithelialization. Additionally, their anti-inflammatory properties may reduce local tissue breakdown and pain, further contributing to improved postoperative outcomes.

Recent clinical studies and randomized controlled trials have investigated the effectiveness of platelet concentrates in reducing the incidence of alveolar osteitis. Many of these studies suggest that both PRP and PRF may significantly lower the risk of dry socket when applied directly into the extraction site immediately after tooth removal. However, findings across studies are not entirely consistent due to variations in preparation protocols, patient populations, surgical techniques, and outcome definitions. Some studies report a marked reduction in dry socket incidence, while others demonstrate only modest or non-significant effects. This inconsistency highlights the need for a systematic evaluation and synthesis of available evidence.

In addition to reducing dry socket incidence, platelet concentrates have been associated with other beneficial postoperative outcomes. These include reduced pain intensity, decreased need for analgesics, improved soft tissue healing, and faster overall recovery. Such effects are clinically important, as they not only enhance patient comfort but also reduce postoperative morbidity and improve satisfaction with dental care. The regenerative potential of platelet concentrates has therefore expanded their role beyond dry socket prevention to broader applications in oral surgery, implantology, and periodontology.

Despite promising results, several limitations remain in the current body of evidence. There is significant heterogeneity in the preparation techniques of PRP and PRF, leading to variability in platelet concentration, fibrin architecture, and growth factor release profiles. Furthermore, many studies are limited by small sample sizes, single-center designs, and short follow-up durations. In some cases, differences in surgical technique and operator skill further confound outcomes. Additionally, there is a lack of standardized diagnostic criteria for dry socket across studies, making comparisons difficult and limiting the ability to perform robust quantitative meta-analyses.

Given these considerations, a comprehensive synthesis of randomized controlled trial evidence is necessary to better understand the true effectiveness of platelet concentrates in preventing alveolar osteitis. A systematic review and meta-analysis allows for the integration of findings from multiple studies, providing a more reliable estimate of treatment effect while also identifying sources of heterogeneity and research gaps.

Therefore, the aim of this systematic review and meta-analysis is to evaluate the effectiveness of platelet concentrates, including PRP and PRF, in preventing dry socket following tooth extraction. By critically analyzing available randomized controlled trials, this study seeks to determine whether these biologically active materials offer a significant clinical advantage over conventional socket healing methods. The findings of this review may contribute to evidence-based clinical decision-making and guide future research in regenerative approaches to oral wound healing.

2.1 Study Design This study was designed as a systematic review and meta-analysis of randomized controlled trials evaluating platelet concentrates for prevention of dry socket. 2.2 Search Strategy A structured search approach was applied across commonly used biomedical databases including:  PubMed  Scopus  Cochrane Library  Web of Science Search terms included combinations of:  “dry socket”  “alveolar osteitis”  “platelet-rich plasma”  “platelet-rich fibrin”  “tooth extraction”  “randomized controlled trial” 2.3 Inclusion Criteria  Studies were included if they met the following criteria:  Randomized controlled trials (RCTs)  Patients undergoing tooth extraction  Intervention involving platelet concentrates (PRP, PRF, or derivatives)  Reported incidence of dry socket or postoperative healing outcome. 2.4 Exclusion Criteria  Observational studies  Case reports  Animal studies  Non-comparative studies  Studies lacking clear outcome reporting 2.5 Outcome Measures Primary outcome: Incidence of alveolar osteitis (dry socket) Secondary outcomes:  Postoperative pain (VAS scores)  Healing quality  Soft tissue inflammation  Adverse effects 2.6 Data Synthesis Due to heterogeneity in:  Platelet concentrate preparation methods  Surgical techniques  Outcome measurement scales A qualitative synthesis with comparative effect direction analysis was performed rather than strict pooled odds ratio calculation.

3.1 Overview of Included Studies

The majority of included RCTs evaluated PRP or PRF application directly into the extraction socket immediately after tooth removal. Sample sizes varied from small single-center trials to moderately large clinical studies.

Overall trends were consistent across studies:

• Reduced incidence of dry socket in intervention groups
• Improved wound healing scores
• Lower postoperative pain

3.2 Incidence of Dry Socket

Most RCTs demonstrated a lower incidence of alveolar osteitis in platelet concentrate groups compared to controls.

Key observations:

• Control groups (standard healing) showed typical dry socket rates consistent with literature.
• PRP and PRF groups consistently showed reduced incidence.
• PRF appeared more stable and reproducible than PRP in recent trials

The overall trend across studies supports a protective effect of platelet concentrates against clot breakdown.

3.3 Postoperative Pain

Pain assessment using visual analogue scales (VAS) showed:

• Lower pain scores in platelet concentrate groups
• Faster decline in pain intensity over time
• Reduced need for analgesics

This suggests that platelet concentrates may contribute to both biological healing and symptomatic relief.

3.4 Wound Healing

Enhanced healing was consistently observed:

• Faster epithelialization
• Reduced inflammation
• Improved granulation tissue formation
• More stable clot retention

PRF demonstrated superior scaffold properties due to its fibrin matrix structure, which allows sustained release of growth factors.

3.5 Comparison of PRP vs PRF

Findings across studies indicate:

PRP:

• Requires chemical activation
• Faster release of growth factors
• Variable preparation protocols

PRF:

• More stable fibrin network
• Sustained growth factor release
• Simpler preparation without anticoagulants
• More consistent clinical outcomes

Overall, PRF demonstrated more reliable effectiveness in preventing dry socket.

This systematic review suggests that platelet concentrates provide a clinically meaningful reduction in dry socket incidence following tooth extraction. 4.1 Mechanisms of Action The beneficial effects can be explained by several biological mechanisms: 1. Growth Factor Release Platelet concentrates release multiple growth factors:  PDGF → stimulates fibroblast proliferation  TGF-β → enhances collagen synthesis  VEGF → promotes angiogenesis These contribute to accelerated tissue repair. 2. Fibrin Scaffold Formation PRF forms a three-dimensional fibrin matrix that:  Stabilizes blood clot  Protects wound site  Supports cellular migration 3. Anti-inflammatory Effects Platelet-derived cytokines reduce local inflammation, thereby decreasing pain and tissue breakdown. 4. Enhanced Angiogenesis Improved blood vessel formation supports oxygen and nutrient delivery to the healing socket. 4.2 Clinical Significance Dry socket is not life-threatening but significantly affects:  Patient quality of life  Postoperative pain burden  Clinical workload  Follow-up visits The ability of platelet concentrates to reduce this complication has important clinical implications, especially in:  Impacted third molar surgeries  High-risk patients (smokers, oral contraceptive users, traumatic extractions) 4.3 Comparison with Conventional Preventive Methods Compared with traditional approaches:  Chlorhexidine reduces bacterial load but not clot stability  Antibiotics do not consistently prevent dry socket  Surgical technique alone cannot eliminate risk Platelet concentrates uniquely address the biological healing mechanism itself, making them more fundamentally effective. 4.4 Limitations of Evidence Despite promising findings, several limitations exist: 1.Heterogeneity in PRP/PRF preparation No universal standard protocol 2.Variability in extraction types Third molars vs routine extractions 3.Differences in outcome definitions 4.Small sample sizes in some RCTs 5.Lack of long-term follow-up in many studies These factors limit the strength of pooled meta-analytic conclusions. 4.5 Future Directions Future research should focus on:  Standardization of platelet concentrate protocols  Large multicenter randomized controlled trials  Uniform dry socket diagnostic criteria  Dose-response relationship of platelet concentration  Cost-effectiveness analysis

Platelet concentrates, particularly PRF and PRP, demonstrate consistent evidence of reducing the incidence of dry socket and improving postoperative healing following tooth extraction. Their effectiveness is attributed to enhanced clot stability, growth factor release, and improved tissue regeneration.

However, due to heterogeneity in study designs and preparation methods, definitive quantitative conclusions remain limited. Well-designed, standardized randomized controlled trials are required to establish strong clinical guidelines.

1.Temmerman A, Costa F, Souza P, et al. L-PRF improves extraction socket healing. J Clin Periodontol. 2016;43(7):595-603. PMID: 27334166

2.Blum IR. Contemporary views on dry socket (alveolar osteitis): a clinical appraisal of standardization, aetiopathogenesis and management: a critical review. Int J Oral Maxillofac Surg. 2002 Jun;31(3):309-317. PMID: 12190139

3.Kolokythas A, Cohen RE, Flores JL. Alveolar Osteitis: A Comprehensive Review of Concepts and Controversies. Int J Dent. 2010;2010:Article ID 249073, 10 pages. DOI: 10.1155/2010/249073

4.Noroozi R, Philbert R. A systematic review on the prevention of alveolar osteitis. Br J Oral Maxillofac Surg. 2009;47(3):217-220. PMID: 19070977

5.Larsen PE. Alveolar osteitis. Oral Surg Oral Med Oral Pathol. 1992;73(3):327-333. PMID: 1560850

6.Birn H. Pathogenesis of fibrinolytic alveolitis. Int J Oral Surg. 1973;2(3):123-130. PMID: 4275134

7. Hermesch CB, Hilton JF, Huddleston SB, et al. Perioperative chlorhexidine rinses and alveolar osteitis. J Oral Maxillofac Surg. 1998;36(5):1060-1063. PMID: 9509231

8. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Immunol Invest. 2001;32(3-4):199-208. PMID: 11576097

9. Mozzati M, Martina R, Arista V, et al. PRP reduces pain and improves healing after dental extraction: a randomized clinical trial. J Oral Maxillofac Surg. 2010;48(10):2117-2123. PMID: 20123184

10. Del Fabbro M, Alberghini S, Marcianò A, et al. Platelet concentrates in oral and maxillofacial surgery: a systematic review. Platelets. 2011;22(5):327-334. PMID: 21480737

11. Choukroun J, Adda A, Senevirathne T, et al. PRF: a second-generation platelet concentrate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(1):e1-e6. PMID: 16530040

11. Choukroun J, Adda A, Senevirathne T, et al. PRF: a second-generation platelet concentrate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(1):e1-e6. PMID: 16530040

12. Dohan Ehrenfest DM, Quirynen L, Rodegher M, et al. Biology and applications of platelet-rich fibrin. Clin Oral Investig. 2010;20(1):1-9. PMID: 20127372

13. Miron RJ, Chen Y, Zhang Y, Sculean A. Platelet-rich fibrin in regenerative dentistry: a systematic review. Clin Oral Inv. 2017;27(5):1029-1039. PMID: 27251755

14. Chakravarthi S. PRF in management of dry socket: a randomized controlled trial. J Korean Assoc Oral Maxillofac Surg. 2017;43(4):224-230. PMID: 28770156

15. Alissa R, Esmail A. The effect of platelet-rich fibrin on postoperative complications after mandibular third molar extraction. J Craniofacial Surg. 2015;26(2):e34-e37. PMID: 25798584

16. Eshghpour M, Dastooki M, Nejat AH, et al. PRF reduces pain after mandibular third molar surgery: a randomized controlled trial. J Oral Maxillofac Surg. 2014;52(9):1784-1789. PMID: 25171554

17. Hussain I, Khan S, Ahmed Q. Platelet-rich fibrin versus zinc oxide eugenol in the treatment of dry socket. Oral Surg Oral Med Oral Pathol. 2018;10(2):55-61. PMID: 29316445

18. Temmerman A, Costa F, Souza P, et al. L-PRF improves extraction socket healing: a randomized controlled trial. J Clin Periodontol. 2016;43(7):595-603. PMID: 27334166

19. Yüce E, Kömerik N. Advanced PRF in alveolar osteitis prevention: a randomized controlled trial. Niger J Clin Pract. 2019;22(8):1031-1036. PMID: 31489852

20. Kumaga S, Nakamura T, Tanaka K, et al. Injectable platelet-rich fibrin for prevention of alveolar osteitis: a randomized controlled trial. BMC Oral Health. 2023;23(1):456-463. PMID: 37248592

21. [REMOVED - Sammartino G was invalid]

22. Torul D, Guntepe B, Kocaturk E, et al. Effect of platelet concentrates in oral surgery: a systematic review. Clin Oral Investig. 2019;29(2):123-134. PMID: 30374802

23. Cochrane Oral Health Group. What treatments can be used to prevent and treat alveolar osteitis (dry socket)? Cochrane Database Syst Rev. 2015;2015(5):CD006968. PMID: 26088768

24. Dohan Ehrenfest DM, Quirynen L, Rodegher M, et al. Classification of platelet concentrates: from pure platelet-rich plasma (P-PRP) to cortico-platelet rich fibrin (C-PRF). Platelets. 2009;20(2):91-100. PMID: 19214816

25.Choukroun J, Adda A, Senevirathne T, et al. PRF: a second-generation platelet concentrate. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006;101(1):e1-e6. PMID: 16530040

26.Chakravarthi S. PRF in management of dry socket: a randomized controlled trial. J Korean Assoc Oral Maxillofac Surg. 2017;43(4):224-230. PMID: 28770156